Aurora Advanced Healthcare N=1479	82.01 %
Aurora Medical Group N=4205	87.51 %
Aurora UW Medical Group N=316	85.13 %
Bellin Medical Group N=206	88.35 %
Columbia St. Mary's Community Physicians N=296	81.42 %
Dean Clinic N=561	81.28 %
Froedtert Health Medical Group - Menomonee Falls Division N=199	65.83 %
Froedtert Health Medical Group - West Bend Clinic N=192	79.17 %
Gundersen Clinic, Ltd N=3653	82.34 %
Marshfield Clinic N=5604	87.12 %
Mayo Clinic Health System - Franciscan Healthcare N=669	73.54 %
Mayo Clinic Health System in Eau Claire N=929	81.05 %
Medical College Physicians N=1267	80.58 %
Mercy Health System N=479 n=479	77.04 %
Meriter Medical Group N=74	82.43 %
Monroe Clinic N=670	90.90 %
Prevea Health N=403	83.13 %
ProHealth Care Medical Associates N=634	86.75 %
ThedaCare Physicians N=1601	93.38 %
UW Health Physicians N=1270	76.69 %
Wheaton Franciscan Medical Group N=371	71.16 %

Chronic kidney disease (CKD) is a major public health problem. Improving outcomes for people with CKD requires a coordinated world-wide approach to prevention of adverse outcomes. Interventions during the earlier stages of kidney disease includes evaluation and management of co-morbid conditions, slowing progression of kidney disease, cardiovascular disease risk reduction, preventing and treating complications of CKD.

The National Kidney Foundation (NKF) recommends that low-density lipoprotein cholesterol (LDL-C) should be < 100 mg/dL for all patients with CKD in Stages I, II or III and that patients should have one test annually, at a minimum.

This measure shows the percentage of people 18-85 years of age with a diagnosis of CKD in stage I, II or III, excluding those with CKD in stages IV or V or with End Stage Renal Disease (ESRD) who received an LDL-cholesterol test in the measurement year.